SiNtx Shares Surge on Patent Allowance for Biomedical Material

Dow Jones09-10

By Josh Beckerman

SiNtx Technologies shares surged on heavy volume after the silicon-nitride producer said its application for a U.S. patent on production of a ceramic material used in medicine had been approved.

The stock, which touched a 52-week low of $2.75 on Friday, was up 74% to $4.99 Monday. Shares are down about 93% this year. Volume was more than 63 million shares, compared with a 65-day average of 92,261.

The Salt Lake City company said the patent covers novel methods of bonding bioactive silicon nitride, or mixtures of silicon nitride and bioactive glass, to zirconia-toughened alumina and similar material surfaces. This invention is designed to impart silicon nitride's beneficial biomedical properties, the company said.

The allowance is expected to result in the issuance of a patent after the completion of administrative processes. SiNtx said it now has 16 issued patents in the U.S. and an additional 84 pending patent applications in worldwide.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

September 09, 2024 14:35 ET (18:35 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466119070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-10 02:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466119070","market":"other","top_or_hot":-1,"title":"SiNtx Shares Surge on Patent Allowance for Biomedical Material","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  SiNtx Technologies shares surged on heavy volume after the silicon-nitride producer said its application for a U.S. patent on production of a ceramic material used in medicine had been approved. \n</p>\n<p>\n  The stock, which touched a 52-week low of $2.75 on Friday, was up 74% to $4.99 Monday. Shares are down about 93% this year. Volume was more than 63 million shares, compared with a 65-day average of 92,261. \n</p>\n<p>\n  The Salt Lake City company said the patent covers novel methods of bonding bioactive silicon nitride, or mixtures of silicon nitride and bioactive glass, to zirconia-toughened alumina and similar material surfaces. This invention is designed to impart silicon nitride's beneficial biomedical properties, the company said. \n</p>\n<p>\n  The allowance is expected to result in the issuance of a patent after the completion of administrative processes. SiNtx said it now has 16 issued patents in the U.S. and an additional 84 pending patent applications in worldwide. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 09, 2024 14:35 ET (18:35 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SiNtx Shares Surge on Patent Allowance for Biomedical Material</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSiNtx Shares Surge on Patent Allowance for Biomedical Material\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-10 02:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Josh Beckerman \n\n\n \n\n\n  SiNtx Technologies shares surged on heavy volume after the silicon-nitride producer said its application for a U.S. patent on production of a ceramic material used in ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2466119070","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466119070","pubTimestamp":1725906900,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"SiNtx Technologies shares surged on heavy volume after the silicon-nitride producer said its application for a U.S. patent on production of a ceramic material used in medicine had been approved.The stock, which touched a 52-week low of $2.75 on Friday, was up 74% to $4.99 Monday. Shares are down about 93% this year. Volume was more than 63 million shares, compared with a 65-day average of 92,261.The Salt Lake City company said the patent covers novel methods of bonding bioactive silicon nitride, or mixtures of silicon nitride and bioactive glass, to zirconia-toughened alumina and similar material surfaces. This invention is designed to impart silicon nitride's beneficial biomedical properties, the company said.The allowance is expected to result in the issuance of a patent after the completion of administrative processes. SiNtx said it now has 16 issued patents in the U.S. and an additional 84 pending patent applications in worldwide.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SINT":"SINTX Technologies Inc"},"translate_title":"SiNtx股价因生物医学材料专利津贴而飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SINT":1},"content_text":"By Josh Beckerman \n\n\n \n\n\n  SiNtx Technologies shares surged on heavy volume after the silicon-nitride producer said its application for a U.S. patent on production of a ceramic material used in medicine had been approved. \n\n\n  The stock, which touched a 52-week low of $2.75 on Friday, was up 74% to $4.99 Monday. Shares are down about 93% this year. Volume was more than 63 million shares, compared with a 65-day average of 92,261. \n\n\n  The Salt Lake City company said the patent covers novel methods of bonding bioactive silicon nitride, or mixtures of silicon nitride and bioactive glass, to zirconia-toughened alumina and similar material surfaces. This invention is designed to impart silicon nitride's beneficial biomedical properties, the company said. \n\n\n  The allowance is expected to result in the issuance of a patent after the completion of administrative processes. SiNtx said it now has 16 issued patents in the U.S. and an additional 84 pending patent applications in worldwide. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 09, 2024 14:35 ET (18:35 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Policy And Regulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466119070"}